SciCombinator

Discover the most talked about and latest scientific content & concepts.

J Núñez, P Palau, E Domínguez, A Mollar, E Núñez, JM Ramón, G Miñana, E Santas, L Fácila, JL Górriz, J Sanchis and A Bayés-Genís
Abstract
Sodium-glucose linked transporter 2 inhibition recently emerged as a promising therapy for reducing the risk of heart failure (HF) in patients with type 2 diabetes mellitus (T2DM). However, there is a lack of data endorsing its role in symptomatic HF patients. We sought to evaluate the short-term effects of empagliflozin on maximal exercise capacity in these patients.
Tweets*
52
Facebook likes*
0
Reddit*
0
News coverage*
0
Blogs*
0
SC clicks
1
Concepts
Insulin resistance, Diabetes mellitus type 1, Sulfonylurea, Insulin, Hypertension, Diabetes mellitus type 2, Diabetes mellitus, Obesity
MeSH headings
-
comments powered by Disqus

* Data courtesy of Altmetric.com